TherapeuticsMD, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2014 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
TherapeuticsMD, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2014 to Q4 2023.
  • TherapeuticsMD, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2023 was $200K, a 93.3% decline year-over-year.
  • TherapeuticsMD, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2023 was $1.3M, a 88.8% decline year-over-year.
  • TherapeuticsMD, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.3M, a 88.8% decline from 2022.
  • TherapeuticsMD, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $11.6M, a 35.9% decline from 2021.
  • TherapeuticsMD, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $18.1M, a 69.2% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $1.3M $200K -$2.8M -93.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 $4.1M $200K -$4.1M -95.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $8.2M $400K -$1.8M -81.8% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $10M $500K -$1.6M -76.2% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $11.6M $3M -$2.3M -43.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 $13.9M $4.3M -$3M -41.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $16.9M $2.2M -$300K -12% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $17.2M $2.1M -$900K -30% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $18.1M $5.3M Oct 1, 2021 Dec 31, 2021 10-K 2023-04-07
Q3 2021 $7.3M +$4.2M +135% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $2.5M -$500K -16.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $3M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q3 2020 $3.1M +$905K +41.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $3M +$769K +34.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q4 2019 $10.7M $4.13M +$2.02M +95.8% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-23
Q3 2019 $8.68M $2.19M +$85.4K +4.05% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $8.59M $2.23M +$18.6K +0.84% Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $8.57M $2.14M +$483K +29.1% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $8.09M $2.11M +$355K +20.2% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-04
Q3 2018 $7.74M $2.11M +$224K +11.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $7.51M $2.21M +$707K +46.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $6.81M $1.66M +$359K +27.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $6.45M $1.76M -$2.09M -54.3% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-24
Q3 2017 $8.54M $1.89M -$2.1M -52.7% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $10.6M $1.51M -$2.65M -63.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-30
Q1 2017 $13.3M $1.3M -$2.85M -68.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-07
Q4 2016 $16.1M $3.85M +$1.55M +67.7% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 $14.6M $3.98M +$2.36M +145% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $12.2M $4.16M +$2.19M +111% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 $10M $4.15M +$3.42M +470% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 $6.62M $2.29M +$1.24M +118% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-23
Q3 2015 $5.38M $1.63M +$579K +55.3% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-05
Q2 2015 $4.8M $1.97M +$686K +53.2% Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-07
Q1 2015 $4.12M $728K -$278K -27.6% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-07
Q4 2014 $4.39M $1.05M Oct 1, 2014 Dec 31, 2014 10-K 2017-02-28
Q3 2014 $1.05M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 $1.29M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $1.01M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.